Insights on the Levetiracetam Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global levetiracetam market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Levetiracetam is a medication that is sold under the brand name Keppra among others and is used to treat epilepsy. This medicine is used for partial-onset, myoclonic, or tonic-clonic seizures. It is consumed by mouth as an immediate or extended-release formulation or by injecting directly into a vein. The major factor for the growth of the market is the rising prevalence of epilepsy.
According to the World Health
Organization (WHO), in 2019, epilepsy is one of the most common neurological
diseases globally with around 50 million people diagnosed with it.
Additionally, almost 80% of people with epilepsy live in low and middle-income
countries and up to 70% of people living with epilepsy could live seizure-free
if properly diagnosed and treated. However, the risk of mortality is three
times higher in people with epilepsy than in the general populace. Hence the rising
prevalence of epilepsy is driving the demand for levetiracetam which in turn is
boosting the market growth.
To Request a Sample of our Report on Levetiracetam
Market: https://www.omrglobal.com/request-sample/levetiracetam-market
Some major key players in the market include Mylan NV,
UCB Pharma Ltd., and Novartis International AG (Sandoz Inc.), among others. The
market players are contributing significantly to the growth of the market by
the adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in June 2018, Sandoz
Canada announced the launch of Sandoz Levetiracetam 1000 mg to be used as
adjunctive therapy to manage patients with epilepsy who are not satisfactorily
controlled by conventional therapy.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
• Segment
Covered-
·
By Form
·
By Application
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- Mylan NV, UCB
Pharma Ltd., and Novartis International AG (Sandoz Inc.), among others.
(Get 15% Discount on Buying this Report)
A
full Report of Levetiracetam Market is Available at: https://www.omrglobal.com/industry-reports/levetiracetam-market
Global Levetiracetam Market Report by Segment
By Form
• Tablet
• Syrup
• Injection
By Application
• Myoclonic
Treatment
• Tonic-clonic
Seizures Treatment
Global Levetiracetam Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment